DGAP-News: Analogic Announces FDA Clearance for Anesthesia Needle Kit for Use With SonixGPS Ultrasound System

        Print
| Source: EQS Group AG
DGAP-News: Analogic Corporation /
Analogic Announces FDA Clearance for Anesthesia Needle Kit for Use
With SonixGPS Ultrasound System

28.03.2014 / 19:30

---------------------------------------------------------------------

Company to Showcase This Technology at AIUM 2014 Annual Convention

PEABODY, Mass., 2014-03-28 19:30 CET (GLOBE NEWSWIRE) --
Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and
aviation security technology, announced today that it has received 510(k)
clearance from the U.S. Food and Drug Administration (FDA) for the SonixGPS(r)
Nerve Block Needle Kit. The nerve block needles are used with Analogic's
SonixGPS ultrasound technology, which is designed for guidance procedures such
as nerve blocks for pain management and surgery. 

Analogic will highlight this new technology as well as showcase its
SonixTouch(r) 
ultrasound research system, OEM transducers and its OEM ultrasound platform at
the American Institute of Ultrasound in Medicine (AIUM) 2014 Annual Convention
(Booth 100). The convention takes place March 29-April 2 in Las Vegas, Nevada. 

'As ultrasound is used in more areas of patient care, Analogic is providing
solutions that are easier to use, while successfully meeting today's procedure
guidance challenges,' said Lars Shaw, vice president of global marketing for
Analogic. 'As an example, ultrasound technology is often used by physicians to
help guide complex needle procedures because it provides useful visualization
of subsurface anatomy, serving as a 'visual pathway' to the obstacles beneath
the skin's surface. With the SonixGPS, physicians are able to more clearly
visualize and predict the needle's trajectory during invasive procedures in
real time, resulting in the ability to select both the needle direction and
angle that is safest and most comfortable for their patients.' 

The SonixGPS ultrasound guidance system uses multiple position sensors,
including one embedded in the transducer, to provide unique ultrasound guidance
for complex procedures, potentially reducing the learning curve for such
procedures including nerve blocks, vascular access, core biopsies and fine
needle aspirations. Using SonixGPS, physicians can insert the needle from any
direction including in plane with the transducer, or out of plane. As a result,
trajectory may be planned before inserting the needle to reduce unnecessary
tissue manipulation, while maintaining patient comfort. SonixGPS provides a
cost-effective solution that can operate at any depth or angle with consistent
display of tip and needle position during the entire procedure. 

'We are very excited to deliver our innovative SonixGPS needle guidance
technology to anesthesiologists in the United States,' continued Shaw.
'Physicians in other parts of the world have been successfully using this
technology to improve the speed and accuracy of difficult procedures.' 

Analogic's SonixTouch research systems may be configured for pre-clinical and
clinical research using the same imaging platform. Featuring high-frequency
imaging and a complete pre-clinical solution, the SonixTouch systems are
compact, portable and customizable to include a range of new and upcoming
technology such as contrast imaging, elastography, plane wave imaging, strain
imaging and more. In addition, Analogic Ultrasound has the flexibility to
provide various OEM ultrasound platforms and OEM transducers to meet specific
requirements. The open architecture and software development toolkits make it
easy to develop unique user interfaces for new and proprietary medical devices
that incorporate ultrasound imaging for groundbreaking applications. 

The SonixGPS is available on the SonixTouch and SonixTablet(tm) ultrasound
systems, which are equipped with a customizable touch screen interface. Click
here to watch a video featuring Brian Pollard, M.D., who discusses how SonixGPS
technology can assist in improving patient outcomes and optimize safety. 

The SonixTouch Research system offers clinicians the ability to acquire large
cine loops of clinical data ranging from raw radio frequency (RF) signal in
B-mode, color, pulsed wave, 3D/4D modes, or scan-converted data, to either
eight bits or 16 bits of envelope data. To learn more, watch assistant
professors Michael C. Kolios, Ph.D., and Jahan Tavakkoli, Ph.D., from Ryerson
University, discuss their research initiatives using the SonixTouch system:
http://www.analogicultrasound.com/research/biomedical. 

During the AIUM Annual Convention, Kris Dickie, director of engineering and
managing director for Analogic Ultrasound, will present 'Research Interface
Design for Clinical Ultrasound' in the Neapolitan Ballroom I/II at 9:45 am on
April 2. 

About Analogic

Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology
solutions to advance the practice of medicine and save lives. We are recognized
around the world for advanced imaging systems and technology that enable
computed tomography (CT), ultrasound, digital mammography, and magnetic
resonance imaging (MRI), as well as automated threat detection for aviation
security. Our CT, MRI, digital mammography, and ultrasound transducer products
are sold to original equipment manufacturers (OEMs), providing state-of-the-art
capability and enabling them to enter new markets and expand their existing
market presence. Our market-leading BK Medical and Ultrasonix branded
ultrasound systems, used in procedure-driven markets such as urology, surgery,
and point-of-care, are sold to clinical end users through our direct sales
force. For over 40 years we've enabled customers to thrive, improving the
health and enhancing the safety of people around the world. Analogic is
headquartered just north of Boston, Massachusetts. For more information, visit
www.analogic.com. 

Analogic is a registered trademark of Analogic Corporation.

The globe logo is a trademark of Analogic Corporation.


         CONTACT: Media Contact:
         Amy Cook
         (925) 552-7893
         amycook@amcpublicrelations.com
         
         Investor Contact:
         Mark Namaroff
         Director of Investor Relations
         (978) 326-4058
         investorrelations@analogic.com
News Source: NASDAQ OMX


End of Corporate News

---------------------------------------------------------------------

28.03.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English               
Company:     Analogic Corporation  
 
 
             United States         
ISIN:        US0326572072          
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
260492 28.03.2014